Skip to content

GFR PHARMACEUTICALS INC

company.status.inactive

CIK 1096294fmd_05KVHQEHXYPVH9YG3YT0RTMH4NManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2010 to Mar 31, 2013, 12 periods

Latest annual · FY2012

Millions
Total revenues
4
Gross profit
3
Operating income
2
Net income
1
Free cash flow
1

Latest quarter · Q1 FY2013

Millions
Total revenues
1
Gross profit
0
Operating income
0
Net income
0
Free cash flow
0
Open Financials

GFR PHARMACEUTICALS INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2012FY2011ChangeSource
Revenue$4.3 million$4.7 million-8.6%10-K 2013-03-29 · proof
Gross profit$2.8 million$3.5 million-19.7%10-K 2013-03-29 · proof
Operating income$1.8 million$2.7 million-34.3%10-K 2013-03-29 · proof
Net income$1.3 million$2 million-35.2%10-K 2013-03-29 · proof
Cash from operating activities$1.2 million$480,961+149.2%10-K 2013-03-29 · proof
Free cash flow$1.2 million$174,518+582.6%10-K 2013-03-29 · proof
Total assets$12.2 million$12.3 million-1.3%10-K 2013-03-29 · proof
Total liabilities$1.6 million$3.1 million-49.1%10-K 2013-03-29 · proof
Cash and cash equivalents$564,548$460,883+22.5%10-K 2013-03-29 · proof
What was GFR PHARMACEUTICALS INC's revenue in fiscal 2012?
GFR PHARMACEUTICALS INC reported revenue of $4.3 million for fiscal 2012 (the year ended Dec 31, 2012), against $4.7 million the year before (-8.6%). Source: the 10-K filed with the SEC on Mar 29, 2013. SEC
What was GFR PHARMACEUTICALS INC's gross profit in fiscal 2012?
GFR PHARMACEUTICALS INC reported gross profit of $2.8 million for fiscal 2012 (the year ended Dec 31, 2012), against $3.5 million the year before (-19.7%). Source: the 10-K filed with the SEC on Mar 29, 2013. SEC
What was GFR PHARMACEUTICALS INC's operating income in fiscal 2012?
GFR PHARMACEUTICALS INC reported operating income of $1.8 million for fiscal 2012 (the year ended Dec 31, 2012), against $2.7 million the year before (-34.3%). Source: the 10-K filed with the SEC on Mar 29, 2013. SEC
What was GFR PHARMACEUTICALS INC's net income in fiscal 2012?
GFR PHARMACEUTICALS INC reported net income of $1.3 million for fiscal 2012 (the year ended Dec 31, 2012), against $2 million the year before (-35.2%). Source: the 10-K filed with the SEC on Mar 29, 2013. SEC
What was GFR PHARMACEUTICALS INC's cash from operating activities in fiscal 2012?
GFR PHARMACEUTICALS INC reported cash from operating activities of $1.2 million for fiscal 2012 (the year ended Dec 31, 2012), against $480,961 the year before (+149.2%). Source: the 10-K filed with the SEC on Mar 29, 2013. SEC
What was GFR PHARMACEUTICALS INC's free cash flow in fiscal 2012?
GFR PHARMACEUTICALS INC reported free cash flow of $1.2 million for fiscal 2012 (the year ended Dec 31, 2012), against $174,518 the year before (+582.6%). Source: the 10-K filed with the SEC on Mar 29, 2013. SEC
What are GFR PHARMACEUTICALS INC's total assets?
As of Dec 31, 2012, GFR PHARMACEUTICALS INC reported total assets of $12.2 million, against $12.3 million a year earlier (-1.3%). Source: the 10-K filed with the SEC on Mar 29, 2013. SEC
What are GFR PHARMACEUTICALS INC's total liabilities?
As of Dec 31, 2012, GFR PHARMACEUTICALS INC reported total liabilities of $1.6 million, against $3.1 million a year earlier (-49.1%). Source: the 10-K filed with the SEC on Mar 29, 2013. SEC
What are GFR PHARMACEUTICALS INC's cash and cash equivalents?
As of Dec 31, 2012, GFR PHARMACEUTICALS INC reported cash and cash equivalents of $564,548, against $460,883 a year earlier (+22.5%). Source: the 10-K filed with the SEC on Mar 29, 2013. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1096294&period_type=annual&limit=5"

Information only, not investment advice.